Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Auris Medical Holding stock | $2.16

Learn how to easily invest in Auris Medical Holding stock.

Auris Medical Holding Ltd is a biotechnology business based in the US. Auris Medical Holding shares (EARS) are listed on the NASDAQ and all prices are listed in US Dollars. Auris Medical Holding employs 8 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Auris Medical Holding

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – EARS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Auris Medical Holding stock price (NASDAQ: EARS)

Use our graph to track the performance of EARS stocks over time.

Auris Medical Holding shares at a glance

Information last updated 2021-09-17.
Latest market close$2.16
52-week range$0.73 - $5.54
50-day moving average $3.25
200-day moving average $3.41
Wall St. target price$14.95
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.48

Buy Auris Medical Holding shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Public
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Webull
Stocks, Options, ETFs
$0
0%
Get two free stocks valued between $3.00 and $300 with a deposit to any new account.
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Auris Medical Holding stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Auris Medical Holding price performance over time

Historical closes compared with the close of $2.16 from 2021-09-17

1 week (2021-09-10) -15.95%
1 month (2021-08-19) -24.74%
3 months (2021-06-18) -34.94%
6 months (2021-03-19) -46.53%
1 year (2020-09-18) 173.42%
2 years (2019-09-19) -26.53%
3 years (2018-09-19) 650.00%
5 years (2016-09-19) 29.34%

Auris Medical Holding financials

Revenue TTM $174,475
Gross profit TTM $174,475
Return on assets TTM -21.99%
Return on equity TTM -71.91%
Profit margin 0%
Book value $1.47
Market capitalisation $39.2 million

TTM: trailing 12 months

Shorting Auris Medical Holding shares

There are currently 150,091 Auris Medical Holding shares held short by investors – that's known as Auris Medical Holding's "short interest". This figure is 125.7% up from 66,514 last month.

There are a few different ways that this level of interest in shorting Auris Medical Holding shares can be evaluated.

Auris Medical Holding's "short interest ratio" (SIR)

Auris Medical Holding's "short interest ratio" (SIR) is the quantity of Auris Medical Holding shares currently shorted divided by the average quantity of Auris Medical Holding shares traded daily (recently around 1.9 million). Auris Medical Holding's SIR currently stands at 0.08. In other words for every 100,000 Auris Medical Holding shares traded daily on the market, roughly 80 shares are currently held short.

However Auris Medical Holding's short interest can also be evaluated against the total number of Auris Medical Holding shares, or, against the total number of tradable Auris Medical Holding shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Auris Medical Holding's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Auris Medical Holding shares in existence, roughly 10 shares are currently held short) or 0.0124% of the tradable shares (for every 100,000 tradable Auris Medical Holding shares, roughly 12 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Auris Medical Holding.

Find out more about how you can short Auris Medical Holding stock.

Auris Medical Holding share dividends

We're not expecting Auris Medical Holding to pay a dividend over the next 12 months.

Have Auris Medical Holding's shares ever split?

Auris Medical Holding's shares were split on a 1:20 basis on 30 April 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Auris Medical Holding shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Auris Medical Holding shares which in turn could have impacted Auris Medical Holding's share price.

Auris Medical Holding share price volatility

Over the last 12 months, Auris Medical Holding's shares have ranged in value from as little as $0.7255 up to $5.54. A popular way to gauge a stock's volatility is its "beta".

EARS.US volatility(beta: 1.4)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Auris Medical Holding's is 1.4048. This would suggest that Auris Medical Holding's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Auris Medical Holding overview

Auris Medical Holding Ltd. , a clinical-stage biopharmaceutical company, developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy, and CNS disorders. The company's Phase 3 programs under the development include Keyzilen (AM-101) for the treatment of acute inner ear tinnitus; and Sonsuvi (AM-111) for the treatment of acute inner ear hearing loss. It is also developing AM-125 that is in Phase 2 clinical trial for the intranasal treatment of acute peripheral vertigo; AM-201, which has completed Phase 1b clinical trial for the prevention of antipsychotic induced weight gain and drowsiness; and AM-301, a drug-free nasal spray for protection against airborne viruses and allergens, as well as AM-102 for the tinnitus treatment. The company has a collaboration and license agreement with INSERM; and Xigen S. A. to develop, manufacture, and commercialize pharmaceutical products, as well as drug delivery devices and formulations for local administration of therapeutic substances to the inner ear for the treatment of ear disorders.

Auris Medical Holding in the news

There are no recent company news

Frequently asked questions

What percentage of Auris Medical Holding is owned by insiders or institutions?
Currently 5.445% of Auris Medical Holding shares are held by insiders and 5.585% by institutions.
How many people work for Auris Medical Holding?
Latest data suggests 8 work at Auris Medical Holding.
When does the fiscal year end for Auris Medical Holding?
Auris Medical Holding's fiscal year ends in December.
Where is Auris Medical Holding based?
Auris Medical Holding's address is: Clarendon House, Hamilton, Bermuda, HM 11
What is Auris Medical Holding's ISIN number?
Auris Medical Holding's international securities identification number is: BMG0360L1000
What is Auris Medical Holding's CUSIP number?
Auris Medical Holding's Committee on Uniform Securities Identification Procedures number is: G07025102

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site